Abstract
Background/Aim: Leiomyosarcoma is an extremely rare, small bowel neoplasm (2% of all gastrointestinal tumours). Early diagnosis is challenging due to the slow growth of the cancer. The biological behaviour of this group of tumours is aggressive, and the first-line treatment is surgical resection. Patients and Methods: This is a report of 4 cases of small bowel leiomyosarcoma that were treated in the last ten years at Hospital San Martino: one involving the jejunum and three involving the ileum (age range=69-86 years). Three patients underwent surgical resection and one was treated with chemotherapy. Results: All patients who were eligible for surgery underwent radical resection with R0 margins. Mean overall survival was 33 months (range=8-84 months). Conclusion: Specific guidelines for small bowel leiomyosarcoma do not currently exist and these rare cases should be discussed in a multidisciplinary context. The first treatment approach is surgery, and in some cases, multivisceral resection may be needed to obtain free margins, even in recurrent cases.
Author supplied keywords
Cite
CITATION STYLE
Ferrari, C., Di Domenico, S., Mascherini, M., Santoliquido, M., Mastracci, L., & De Cian, F. (2020). Recurrent leiomyosarcoma of the small bowel: A case series. In Anticancer Research (Vol. 40, pp. 4199–4204). International Institute of Anticancer Research. https://doi.org/10.21873/ANTICANRES.14420
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.